ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,ont,comparison
GO:0098562,cytoplasmic side of membrane,144,0.448708141834598,1.82623792784988,0.003584229390681,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000785,chromatin,388,0.318170876241903,1.4286345396723,0.00363636363636364,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005912,adherens junction,413,0.394252536638781,1.76383344026737,0.00363636363636364,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0019898,extrinsic component of membrane,209,0.340335883465239,1.46620577639205,0.00363636363636364,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0030686,90S preribosome,23,-0.708780615114634,-2.06462654189192,0.003690036900369,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0070161,anchoring junction,426,0.388679228882743,1.74368202727587,0.0037037037037037,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005925,focal adhesion,351,0.401720138140345,1.76957020123744,0.00371747211895911,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0043235,receptor complex,217,0.369869649088455,1.55461321911366,0.00371747211895911,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0009898,cytoplasmic side of plasma membrane,132,0.475529633878874,1.89178764743212,0.00373134328358209,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0030286,dynein complex,38,-0.512572207393758,-1.68611533071514,0.00373134328358209,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0030684,preribosome,49,-0.702604639399516,-2.4209672536508,0.00373134328358209,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031012,extracellular matrix,221,0.356131387258174,1.5088893470869,0.00373134328358209,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031093,platelet alpha granule lumen,38,0.594670757396606,1.91345077268492,0.00374531835205993,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0060205,cytoplasmic membrane-bounded vesicle lumen,60,0.521034931560491,1.83104027623856,0.00374531835205993,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005924,cell-substrate adherens junction,354,0.401332843188263,1.76632195860118,0.0037593984962406,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044291,cell-cell contact zone,52,0.49366172948867,1.7082473728648,0.0037593984962406,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,78,0.549744153154894,1.99221686345292,0.00377358490566038,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031983,vesicle lumen,61,0.53474209373894,1.88032184135492,0.00377358490566038,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0042734,presynaptic membrane,32,0.64699658603977,2.05913263835971,0.00377358490566038,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005911,cell-cell junction,288,0.345155877182373,1.51274244199937,0.00378787878787879,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0030055,cell-substrate junction,358,0.399986836766063,1.76164166849083,0.00378787878787879,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0030139,endocytic vesicle,218,0.332384743233461,1.39271057778561,0.00378787878787879,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031252,cell leading edge,307,0.363098371802816,1.61490235674589,0.00378787878787879,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0098797,plasma membrane protein complex,346,0.359861665718416,1.5976088851652,0.00378787878787879,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000323,lytic vacuole,448,0.306487574518373,1.40579174251975,0.00381679389312977,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005764,lysosome,448,0.306487574518373,1.40579174251975,0.00381679389312977,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031253,cell projection membrane,215,0.358054300143435,1.54752176302855,0.00381679389312977,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0034774,secretory granule lumen,44,0.58252501548576,1.94381718211976,0.00381679389312977,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000790,nuclear chromatin,258,0.366805309429817,1.57923090681278,0.00383141762452107,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0032040,small-subunit processome,32,-0.741084292036007,-2.35632735700196,0.00384615384615385,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005938,cell cortex,202,0.33381064915898,1.41072610928761,0.00386100386100386,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0098552,side of membrane,347,0.37136730250126,1.64493557794146,0.00389105058365759,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000786,nucleosome,73,0.57110242352882,2.08992585058344,0.00390625,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0015629,actin cytoskeleton,370,0.326284000787733,1.45445236185484,0.00390625,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0001726,ruffle,142,0.410383681350463,1.66810699038897,0.00393700787401575,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0045121,membrane raft,245,0.34472207008362,1.47316037966841,0.00393700787401575,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005834,heterotrimeric G-protein complex,23,0.77560142500457,2.19873092653129,0.00395256916996047,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005868,cytoplasmic dynein complex,15,-0.781329801557671,-2.10572788410296,0.00395256916996047,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044452,nucleolar part,58,-0.571225833601825,-1.97264527364346,0.00395256916996047,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0098857,membrane microdomain,246,0.343360801974969,1.46748162765389,0.00395256916996047,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0019897,extrinsic component of plasma membrane,108,0.483326929867467,1.83857630137081,0.00396825396825397,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0008305,integrin complex,25,0.733959568942627,2.1383420199105,0.00398406374501992,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031256,leading edge membrane,108,0.424010200824978,1.66063217587928,0.00398406374501992,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0036477,somatodendritic compartment,470,0.270726118285313,1.2407114911787,0.00398406374501992,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0098636,protein complex involved in cell adhesion,25,0.733959568942627,2.1383420199105,0.00398406374501992,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005759,mitochondrial matrix,369,-0.323206309354283,-1.47575326729819,0.00403225806451613,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0055038,recycling endosome membrane,39,0.582414777964357,1.84636490246959,0.00403225806451613,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0030880,RNA polymerase complex,119,-0.396999786900237,-1.58288249991626,0.00404858299595142,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000314,organellar small ribosomal subunit,25,-0.660293057578177,-1.97817426761761,0.00408163265306122,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005763,mitochondrial small ribosomal subunit,25,-0.660293057578177,-1.97817426761761,0.00408163265306122,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000428,DNA-directed RNA polymerase complex,118,-0.392174663304908,-1.55540880354567,0.00409836065573771,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0055029,nuclear DNA-directed RNA polymerase complex,118,-0.392174663304908,-1.55540880354567,0.00409836065573771,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005643,nuclear pore,70,-0.497958451007669,-1.81355442641986,0.00411522633744856,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044815,DNA packaging complex,79,0.527351295512405,1.92162985165523,0.00420168067226891,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000776,kinetochore,117,-0.404120481154472,-1.60668236359824,0.00423728813559322,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044438,microbody part,77,-0.493128117220611,-1.82930482496504,0.00427350427350427,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044439,peroxisomal part,77,-0.493128117220611,-1.82930482496504,0.00427350427350427,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005778,peroxisomal membrane,53,-0.592261155175628,-2.05238652927387,0.00429184549356223,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0031903,microbody membrane,53,-0.592261155175628,-2.05238652927387,0.00429184549356223,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0042599,lamellar body,13,0.713204957981815,1.7645225775979,0.00431034482758621,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005814,centriole,89,-0.397041074278142,-1.51096723075316,0.0043859649122807,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0098687,chromosomal region,308,-0.326121316567834,-1.4536137177465,0.0043859649122807,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000775,chromosome, centromeric region,169,-0.371091955229576,-1.54640504418464,0.00440528634361234,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044450,microtubule organizing center part,129,-0.37017957829607,-1.50542951471961,0.00442477876106195,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0000313,organellar ribosome,69,-0.54294614236393,-2.01962090630077,0.00444444444444444,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005761,mitochondrial ribosome,69,-0.54294614236393,-2.01962090630077,0.00444444444444444,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005813,centrosome,447,-0.329457317639911,-1.50801566524133,0.00444444444444444,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0005840,ribosome,209,-0.346726710553422,-1.48914860596325,0.00444444444444444,0.0381699346405229,0.0288269693842449,CC,mono-sp-vs-hc
GO:0044433,cytoplasmic vesicle part,446,0.299602665538961,1.3611093982198,0.0072463768115942,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0016528,sarcoplasm,50,0.471659113891594,1.59621901489194,0.0072992700729927,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0005913,cell-cell adherens junction,48,0.492375258323107,1.70046430543,0.00738007380073801,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0072562,blood microparticle,75,0.445002490561713,1.6511820294537,0.00743494423791822,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0005905,coated pit,57,0.441628766495793,1.56775845085218,0.00754716981132075,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0099568,cytoplasmic region,217,0.327204242432134,1.40074801099627,0.00760456273764259,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0030175,filopodium,74,0.436452930169833,1.59850021503577,0.00769230769230769,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0016471,vacuolar proton-transporting V-type ATPase complex,12,0.774461677466431,1.89755909497544,0.00775193798449612,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0098802,plasma membrane receptor complex,126,0.385981790221701,1.51435968065942,0.00775193798449612,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0044455,mitochondrial membrane part,161,0.330488415741787,1.36068853059816,0.00784313725490196,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0030018,Z disc,78,0.406322971714392,1.46927048590282,0.00790513833992095,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0044437,vacuolar part,344,0.295323890543311,1.32492449830807,0.00793650793650794,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0000178,exosome (RNase complex),20,-0.615289187645123,-1.72159345282399,0.00809716599190283,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0043202,lysosomal lumen,65,0.458048077835203,1.62239734066683,0.00809716599190283,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0000315,organellar large ribosomal subunit,31,-0.523291515065586,-1.67222810027672,0.00813008130081301,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0005762,mitochondrial large ribosomal subunit,31,-0.523291515065586,-1.67222810027672,0.00813008130081301,0.0565234223770809,0.0426880208651711,CC,mono-sp-vs-hc
GO:0015030,Cajal body,46,-0.503393884025548,-1.65712370737575,0.00833333333333333,0.0572549019607843,0.0432404540763674,CC,mono-sp-vs-hc
GO:0005777,peroxisome,116,-0.398863029901965,-1.56511462025398,0.00881057268722467,0.0591422350498759,0.0446658191887131,CC,mono-sp-vs-hc
GO:0042579,microbody,116,-0.398863029901965,-1.56511462025398,0.00881057268722467,0.0591422350498759,0.0446658191887131,CC,mono-sp-vs-hc
GO:0007173,epidermal growth factor receptor signaling pathway,310,0.302127672310564,1.33570259930779,0.00337837837837838,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001234,negative regulation of apoptotic signaling pathway,167,0.4091015516122,1.67953825440547,0.00337837837837838,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002576,platelet degranulation,75,0.534115589974227,2.02314256685511,0.00342465753424658,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007265,Ras protein signal transduction,397,0.358717426414365,1.62327355025424,0.00342465753424658,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0038127,ERBB signaling pathway,315,0.302518336296986,1.33380365222355,0.00343642611683849,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007229,integrin-mediated signaling pathway,77,0.487463869167041,1.77664252003957,0.00347222222222222,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043405,regulation of MAP kinase activity,394,0.332260689007691,1.50521765821079,0.00347222222222222,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050801,ion homeostasis,494,0.325725742221624,1.49254006427789,0.00347222222222222,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007160,cell-matrix adhesion,151,0.415056238698133,1.6728998324004,0.00348432055749129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048864,stem cell development,121,0.37665735532935,1.51384110430581,0.00348432055749129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0098771,inorganic ion homeostasis,452,0.335924737984221,1.52832093961221,0.00348432055749129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002218,activation of innate immune response,271,0.340752030600277,1.48288252715684,0.00350877192982456,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043410,positive regulation of MAPK cascade,478,0.329203536576245,1.50853858250916,0.00350877192982456,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044344,cellular response to fibroblast growth factor stimulus,279,0.323916019198454,1.41552989528455,0.00350877192982456,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045089,positive regulation of innate immune response,312,0.326584292924286,1.43695540429481,0.00350877192982456,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0061061,muscle structure development,401,0.324635784981684,1.4735305769314,0.00350877192982456,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010811,positive regulation of cell-substrate adhesion,73,0.457677139909681,1.68086039030947,0.00352112676056338,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031349,positive regulation of defense response,383,0.311940154208075,1.39721572931709,0.00352112676056338,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0038179,neurotrophin signaling pathway,347,0.355667228423433,1.57910386132697,0.00352112676056338,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043434,response to peptide hormone,491,0.356687597639375,1.63583570270893,0.00352112676056338,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048011,neurotrophin TRK receptor signaling pathway,345,0.354639655185997,1.5732131024666,0.00352112676056338,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090201,negative regulation of release of cytochrome c from mitochondria,16,0.687653277620008,1.76111048732633,0.00352112676056338,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000186,activation of MAPKK activity,197,0.375533544958758,1.57501321386613,0.00353356890459364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002758,innate immune response-activating signal transduction,265,0.351355408333066,1.52204570100969,0.00353356890459364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006691,leukotriene metabolic process,26,0.605988629186383,1.86265732885195,0.00353356890459364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008543,fibroblast growth factor receptor signaling pathway,266,0.310331194111326,1.35441777445188,0.00353356890459364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006873,cellular ion homeostasis,398,0.333449217318779,1.49879546610743,0.00354609929078014,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042692,muscle cell differentiation,257,0.335662156029803,1.46430666454217,0.00354609929078014,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071375,cellular response to peptide hormone stimulus,416,0.360526686250133,1.6249069187952,0.00354609929078014,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0038093,Fc receptor signaling pathway,320,0.372916359753324,1.64804282484549,0.00355871886120996,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048013,ephrin receptor signaling pathway,80,0.454573154529654,1.67984005070463,0.00355871886120996,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002220,innate immune response activating cell surface receptor signaling pathway,121,0.392541426061239,1.55597596104172,0.00357142857142857,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0035666,TRIF-dependent toll-like receptor signaling pathway,80,0.42814152642408,1.61741593982298,0.00357142857142857,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048598,embryonic morphogenesis,397,0.328385140468444,1.48519207940127,0.00357142857142857,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008286,insulin receptor signaling pathway,291,0.340793428382848,1.48565073799085,0.003584229390681,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010817,regulation of hormone levels,326,0.329226421115826,1.45590579297429,0.003584229390681,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0055082,cellular chemical homeostasis,497,0.336420375412912,1.54011296518142,0.003584229390681,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070486,leukocyte aggregation,389,0.34324215916721,1.55197702339005,0.003584229390681,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007422,peripheral nervous system development,51,0.516682718766861,1.78889309249475,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031589,cell-substrate adhesion,232,0.412553556607756,1.76085781879921,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032869,cellular response to insulin stimulus,345,0.345894335708218,1.52660320726408,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048010,vascular endothelial growth factor receptor signaling pathway,254,0.408852999734188,1.77071332205944,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051224,negative regulation of protein transport,173,0.403335844512832,1.67268079796072,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070663,regulation of leukocyte proliferation,179,0.361182239603519,1.50970943949557,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090276,regulation of peptide hormone secretion,158,0.41166130921212,1.66269111671997,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0098754,detoxification,70,0.442746611022709,1.62997850511163,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1904950,negative regulation of establishment of protein localization,182,0.40914174882088,1.70366959897409,0.00359712230215827,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,41,0.526407351021043,1.72165371050192,0.0036101083032491,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0038095,Fc-epsilon receptor signaling pathway,264,0.361316939197139,1.5587291525598,0.0036101083032491,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045088,regulation of innate immune response,361,0.33438409424881,1.49029483851255,0.0036101083032491,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001501,skeletal system development,308,0.342651953009216,1.51155382213094,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010810,regulation of cell-substrate adhesion,134,0.371283020043072,1.48061050787779,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030003,cellular cation homeostasis,389,0.324400395579262,1.45004601797859,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030323,respiratory tube development,144,0.372261358771947,1.50742108183925,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050709,negative regulation of protein secretion,84,0.426192313448046,1.5963811646325,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0055080,cation homeostasis,443,0.327150595201722,1.47811728323687,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071229,cellular response to acid chemical,136,0.403589640403041,1.60870806688301,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090087,regulation of peptide transport,204,0.391310233034878,1.63614294717913,0.0036231884057971,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007599,hemostasis,462,0.421914993881105,1.94372070619822,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030073,insulin secretion,160,0.425017605405144,1.73791853500507,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030324,lung development,140,0.376892438052225,1.51881213449553,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032147,activation of protein kinase activity,385,0.334965650154395,1.5044539318035,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0038094,Fc-gamma receptor signaling pathway,76,0.492967570700509,1.80394144119513,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051235,maintenance of location,240,0.379090617767338,1.63532067693896,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051384,response to glucocorticoid,118,0.445831115221792,1.74820907828321,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090066,regulation of anatomical structure size,365,0.331983342948474,1.50192416531979,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1900407,regulation of cellular response to oxidative stress,50,0.479109043353856,1.64514328604105,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903034,regulation of response to wounding,304,0.338286567613514,1.50517495073565,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,78,0.463424419555492,1.69801107754239,0.00363636363636364,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002768,immune response-regulating cell surface receptor signaling pathway,451,0.335836707719213,1.52672967469157,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007009,plasma membrane organization,225,0.369936115038251,1.57740247052419,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007159,leukocyte cell-cell adhesion,414,0.343231479474336,1.56130045059022,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0015980,energy derivation by oxidation of organic compounds,322,0.348141979343482,1.53821099064848,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032868,response to insulin,384,0.346869581372195,1.54732909518892,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048762,mesenchymal cell differentiation,124,0.392690551563872,1.57294370031469,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903649,regulation of cytoplasmic transport,388,0.323633080797979,1.46918908722812,0.00364963503649635,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030168,platelet activation,220,0.505999000145609,2.15848528557634,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032496,response to lipopolysaccharide,273,0.395556535696883,1.72122793956112,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034109,homotypic cell-cell adhesion,436,0.352992494710646,1.60479042106198,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034146,toll-like receptor 5 signaling pathway,69,0.479397246614618,1.74832207561978,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042110,T cell activation,382,0.333921431716348,1.5037992837581,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051591,response to cAMP,72,0.46714413169281,1.68424796272157,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070489,T cell aggregation,382,0.333921431716348,1.5037992837581,0.00366300366300366,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001101,response to acid chemical,243,0.357731340337735,1.53330770263234,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002237,response to molecule of bacterial origin,284,0.384192842581699,1.67051185181204,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,72,0.505792584286843,1.84187003194847,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002791,regulation of peptide secretion,161,0.431084746033283,1.74270930655172,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007032,endosome organization,59,-0.46548158380501,-1.67636130698653,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007411,axon guidance,427,0.338447092290179,1.53616397886099,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030029,actin filament-based process,498,0.338278625331002,1.55923052641734,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030072,peptide hormone secretion,188,0.392021779234809,1.63244163031293,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031668,cellular response to extracellular stimulus,159,0.395472727992883,1.61206515640025,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031960,response to corticosteroid,123,0.426291461317988,1.68339922604529,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034142,toll-like receptor 4 signaling pathway,112,0.396028648786189,1.54909686554364,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0036294,cellular response to decreased oxygen levels,116,0.423606952213379,1.68908335440364,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,72,0.505792584286843,1.84187003194847,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045669,positive regulation of osteoblast differentiation,44,0.522650862602086,1.74152586465047,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050817,coagulation,460,0.418587477749481,1.93239202655801,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,301,0.371973930571185,1.62265844454748,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060485,mesenchyme development,155,0.397734985454926,1.63992091182591,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071396,cellular response to lipid,417,0.338592487958915,1.53495717485308,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0097485,neuron projection guidance,427,0.338447092290179,1.53616397886099,0.00367647058823529,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002526,acute inflammatory response,104,0.429163282168821,1.67978389038857,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0015672,monovalent inorganic cation transport,379,0.327539922307699,1.49358654866589,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030036,actin cytoskeleton organization,439,0.339673221120808,1.55353695036832,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032692,negative regulation of interleukin-1 production,16,0.747499715777011,1.98233143652673,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032922,circadian regulation of gene expression,51,0.551733231275103,1.91961896743031,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045815,positive regulation of gene expression, epigenetic,71,0.441856147494783,1.59785610790304,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050796,regulation of insulin secretion,140,0.441562360017006,1.75423196631679,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071593,lymphocyte aggregation,383,0.332585021065141,1.49660906442076,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0097305,response to alcohol,269,0.382817109286127,1.67469903213599,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1901653,cellular response to peptide,431,0.367730148256814,1.65357103989151,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1990748,cellular detoxification,67,0.424009411361863,1.53939214317694,0.003690036900369,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002224,toll-like receptor signaling pathway,148,0.385513846699097,1.55598505849952,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002756,MyD88-independent toll-like receptor signaling pathway,83,0.415073835939579,1.5668266699033,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006091,generation of precursor metabolites and energy,394,0.35966359990677,1.61768558196653,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0015992,proton transport,122,0.445010968705528,1.74629095023753,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0023061,signal release,301,0.331021753213296,1.45556786017397,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034138,toll-like receptor 3 signaling pathway,94,0.394824164085623,1.52096395327065,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034166,toll-like receptor 10 signaling pathway,68,0.482422887070875,1.75524455172753,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044057,regulation of system process,337,0.336190853170652,1.51550185328015,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071384,cellular response to corticosteroid stimulus,40,0.541102020026798,1.7555442044964,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071456,cellular response to hypoxia,109,0.470290503849032,1.86237340263847,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0098660,inorganic ion transmembrane transport,485,0.351827253158248,1.62411507937564,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1901655,cellular response to ketone,62,0.5241834250447,1.85942718483821,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,26,0.633545347510241,1.89103561307921,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1902532,negative regulation of intracellular signal transduction,373,0.330675239631636,1.47987015361672,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903522,regulation of blood circulation,196,0.382907382587709,1.60978997278043,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001233,regulation of apoptotic signaling pathway,333,0.354306196849936,1.57078261250182,0.0037037037037037,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007596,blood coagulation,457,0.422988985292846,1.94693859670412,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0019693,ribose phosphate metabolic process,400,0.308397687094366,1.38554662116184,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0022407,regulation of cell-cell adhesion,320,0.368856193152558,1.62027888568542,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032963,collagen metabolic process,71,0.474998823248808,1.70542983493592,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048514,blood vessel morphogenesis,368,0.358433454176173,1.61262826357862,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071385,cellular response to glucocorticoid stimulus,38,0.601904449888804,1.91334184597838,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1990089,response to nerve growth factor,30,0.586308996456926,1.84156908612283,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001242,regulation of intrinsic apoptotic signaling pathway,133,0.438952310550401,1.779073889818,0.00371747211895911,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032943,mononuclear cell proliferation,221,0.328215556253547,1.40444235939584,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045785,positive regulation of cell adhesion,305,0.361523735173282,1.58827280679025,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050727,regulation of inflammatory response,218,0.35812605513569,1.5423913810697,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050900,leukocyte migration,282,0.348461561844519,1.53310630166329,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0055065,metal ion homeostasis,406,0.332326768977163,1.48774167497055,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,23,0.631509049546819,1.85783482701153,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903037,regulation of leukocyte cell-cell adhesion,260,0.34782584859446,1.50502819407399,0.00373134328358209,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006979,response to oxidative stress,336,0.302582433390303,1.359246187807,0.00374531835205993,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030100,regulation of endocytosis,165,0.353538308429929,1.46767205910608,0.00374531835205993,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030278,regulation of ossification,131,0.386749219323042,1.52649997882992,0.00374531835205993,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030855,epithelial cell differentiation,381,0.304610860125486,1.36466281210947,0.00374531835205993,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032944,regulation of mononuclear cell proliferation,175,0.363902366489841,1.5115555356069,0.00374531835205993,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006006,glucose metabolic process,192,0.31550898116495,1.34448903194029,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006875,cellular metal ion homeostasis,359,0.32509072449539,1.43645859398926,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009914,hormone transport,228,0.371741857468132,1.57409724533195,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0036293,response to decreased oxygen levels,240,0.357321829196409,1.55365391945441,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0040008,regulation of growth,490,0.342748545642144,1.5871230270186,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046879,hormone secretion,223,0.373243525151608,1.58362637291801,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060047,heart contraction,172,0.358020904825716,1.46606363197293,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070661,leukocyte proliferation,227,0.329608657484192,1.4130725615263,0.0037593984962406,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002253,activation of immune response,472,0.325155982494279,1.48467757701458,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006163,purine nucleotide metabolic process,394,0.307005723665411,1.38109684465531,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008154,actin polymerization or depolymerization,156,0.370315850200432,1.52782808474367,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009617,response to bacterium,400,0.390743967339835,1.76697399441307,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0022408,negative regulation of cell-cell adhesion,115,0.427736912297469,1.64488808010653,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0033619,membrane protein proteolysis,49,0.549714050034704,1.8506283052325,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042886,amide transport,265,0.376393753148944,1.62426927882884,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,220,0.332029147456336,1.41912943115161,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048638,regulation of developmental growth,219,0.340355749922736,1.46351493544166,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050870,positive regulation of T cell activation,180,0.348177994036601,1.45017004027528,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071496,cellular response to external stimulus,220,0.385704023674915,1.62880024157968,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1901654,response to ketone,138,0.455100461397815,1.8429834174124,0.00377358490566038,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002757,immune response-activating signal transduction,433,0.32315862118093,1.46630376126897,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006816,calcium ion transport,266,0.363196721478006,1.57729802253685,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,20,0.645752675474848,1.80853023780668,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0022604,regulation of cell morphogenesis,403,0.350396747518889,1.58099055515307,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032845,negative regulation of homeostatic process,145,0.375197396573694,1.53360917871679,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032965,regulation of collagen biosynthetic process,27,0.553259792964353,1.69247252272408,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034110,regulation of homotypic cell-cell adhesion,268,0.349959330281964,1.51814388354861,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034599,cellular response to oxidative stress,201,0.334945340957811,1.40638472201444,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046883,regulation of hormone secretion,191,0.388493237379491,1.61198461856973,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050865,regulation of cell activation,406,0.320202157473206,1.44601389075993,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070555,response to interleukin-1,92,0.471489477727458,1.82808101640439,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0072507,divalent inorganic cation homeostasis,289,0.311128170838069,1.36447432974508,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1902882,regulation of response to oxidative stress,54,0.464233481728269,1.62222646339008,0.00378787878787879,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001666,response to hypoxia,232,0.372733774657612,1.61298013853983,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002027,regulation of heart rate,58,0.439824338763979,1.54996325912596,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002429,immune response-activating cell surface receptor signaling pathway,298,0.322325921486131,1.42852026165109,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002431,Fc receptor mediated stimulatory signaling pathway,78,0.499312167982202,1.82076843031776,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006897,endocytosis,497,0.351805699798103,1.62698210710805,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010712,regulation of collagen metabolic process,31,0.585613104275378,1.84564229231337,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034112,positive regulation of homotypic cell-cell adhesion,183,0.352619917735016,1.4669906763969,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034162,toll-like receptor 9 signaling pathway,76,0.448515549580501,1.64426607680775,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045620,negative regulation of lymphocyte differentiation,30,0.589199766804579,1.8103075888711,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046777,protein autophosphorylation,190,0.3513301776302,1.47292754161576,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070372,regulation of ERK1 and ERK2 cascade,168,0.361542763184532,1.50363716884498,0.00380228136882129,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001503,ossification,268,0.356008466383588,1.53043466876596,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002292,T cell differentiation involved in immune response,48,0.507499478564085,1.71248762163287,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008360,regulation of cell shape,112,0.467251634126309,1.81706900045166,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009150,purine ribonucleotide metabolic process,374,0.316724257590154,1.41624007795103,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010522,regulation of calcium ion transport into cytosol,66,0.466220602589614,1.69855579638115,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0015833,peptide transport,248,0.395711043500968,1.68824706976802,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044246,regulation of multicellular organismal metabolic process,32,0.560730750932012,1.78454053121382,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046470,phosphatidylcholine metabolic process,49,0.490465267456552,1.66791199940738,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046651,lymphocyte proliferation,218,0.329297333596369,1.40092413546857,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,20,0.66212370779877,1.85652079070522,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1901222,regulation of NIK/NF-kappaB signaling,36,0.519999204203119,1.68362116122829,0.00381679389312977,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001763,morphogenesis of a branching structure,135,0.384237157985498,1.53297821309906,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0003015,heart process,173,0.357928541561138,1.46259186185072,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007568,aging,232,0.369147301149036,1.59839654290207,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009259,ribonucleotide metabolic process,388,0.311854518630953,1.39624844789997,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010001,glial cell differentiation,135,0.374303871843697,1.50003974552298,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010038,response to metal ion,262,0.324490617245425,1.42614294476306,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032570,response to progesterone,35,0.663066617752964,2.14128723673604,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042439,ethanolamine-containing compound metabolic process,65,0.465551132670574,1.70517216789794,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050863,regulation of T cell activation,253,0.348049169803866,1.50038795936621,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071219,cellular response to molecule of bacterial origin,146,0.441049568165722,1.78234231231517,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0097306,cellular response to alcohol,95,0.465084662225752,1.79398891534627,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903039,positive regulation of leukocyte cell-cell adhesion,184,0.351375681391786,1.46041282498175,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903706,regulation of hemopoiesis,273,0.360826084701283,1.56695175363896,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2000021,regulation of ion homeostasis,141,0.382170996821925,1.54048460728842,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001236,regulation of extrinsic apoptotic signaling pathway,132,0.377618429159305,1.53054307634118,0.00383141762452107,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000462,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),26,-0.626853450409859,-1.87371966805216,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008015,blood circulation,340,0.347173127231022,1.54442118973811,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032204,regulation of telomere maintenance,63,-0.461509776458925,-1.62466450829451,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043620,regulation of DNA-templated transcription in response to stress,61,0.543041561093459,1.91238579144234,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045666,positive regulation of neuron differentiation,217,0.343237758219695,1.48367957666992,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045667,regulation of osteoblast differentiation,87,0.454526018505132,1.69876016930773,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045927,positive regulation of growth,178,0.347201362207236,1.44467399052355,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051924,regulation of calcium ion transport,148,0.411877242693823,1.66746834542443,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060402,calcium ion transport into cytosol,97,0.41321831822076,1.58327805463972,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070296,sarcoplasmic reticulum calcium ion transport,25,0.585752714534854,1.72774528520826,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0098662,inorganic cation transmembrane transport,444,0.357519462130782,1.63717331280414,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,32,0.632360700434277,1.93559433079118,0.00384615384615385,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000723,telomere maintenance,122,-0.401386230030017,-1.60480468471362,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0003013,circulatory system process,342,0.345484383431861,1.53648102991157,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032535,regulation of cellular component size,280,0.33134631658861,1.4482737011878,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0033157,regulation of intracellular protein transport,323,0.330268123265299,1.46203636931907,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046209,nitric oxide metabolic process,66,0.473226608046472,1.68793350408857,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046631,alpha-beta T cell activation,100,0.418609876263675,1.60925955877786,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048732,gland development,330,0.326012808223875,1.43801287810441,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060326,cell chemotaxis,177,0.351342635643146,1.48103745009783,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0061138,morphogenesis of a branching epithelium,124,0.376473747669247,1.48604500121799,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071222,cellular response to lipopolysaccharide,139,0.463319589238499,1.85285852219956,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071706,tumor necrosis factor superfamily cytokine production,98,0.424947850892792,1.59994090626162,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0097193,intrinsic apoptotic signaling pathway,265,0.368972766699254,1.62483091250145,0.00386100386100386,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001568,blood vessel development,439,0.340548208434212,1.55686382585463,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002790,peptide secretion,193,0.408928588132561,1.69976391945316,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006754,ATP biosynthetic process,38,0.535865036319615,1.72696171389653,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006818,hydrogen transport,124,0.446234413786693,1.73810327581192,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010470,regulation of gastrulation,23,0.685588149575445,1.94122868009614,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,24,0.603058683106502,1.75680419005481,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0022409,positive regulation of cell-cell adhesion,204,0.350367404937325,1.46792627124535,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030490,maturation of SSU-rRNA,31,-0.636866051188363,-1.95772497248019,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0033002,muscle cell proliferation,116,0.377240081492595,1.48840099322445,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034134,toll-like receptor 2 signaling pathway,82,0.438638342245953,1.61998041836316,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043269,regulation of ion transport,386,0.332020500831404,1.4998831303404,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060669,embryonic placenta morphogenesis,22,0.631487587392671,1.79787834595065,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070371,ERK1 and ERK2 cascade,178,0.360592139946452,1.50377804538796,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903514,calcium ion transport from endoplasmic reticulum to cytosol,24,0.603058683106502,1.75680419005481,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903533,regulation of protein targeting,256,0.340186577222589,1.46998686150845,0.00387596899224806,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006509,membrane protein ectodomain proteolysis,35,0.554540919016559,1.74001393525911,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007250,activation of NF-kappaB-inducing kinase activity,16,0.672412520618323,1.76792465240472,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008637,apoptotic mitochondrial changes,109,0.406126637066931,1.57485317146985,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009205,purine ribonucleoside triphosphate metabolic process,194,0.355640980968819,1.47937657102775,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030099,myeloid cell differentiation,302,0.305953440675122,1.34336425352693,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0033235,positive regulation of protein sumoylation,11,-0.76889279156246,-1.79685671623277,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051028,mRNA transport,126,-0.412444830870837,-1.66562336221749,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051208,sequestering of calcium ion,86,0.453369051762075,1.69739530488793,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051258,protein polymerization,196,0.370134448889431,1.55871149819522,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051282,regulation of sequestering of calcium ion,83,0.455320252717027,1.70545407271133,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001057,reactive nitrogen species metabolic process,70,0.462745483568184,1.67604982358118,0.00389105058365759,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001944,vasculature development,459,0.3405996404511,1.56619049845764,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002286,T cell activation involved in immune response,67,0.467508754477233,1.67094432791075,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006405,RNA export from nucleus,90,-0.459539567186747,-1.74042644037275,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007623,circadian rhythm,152,0.440480973886369,1.79276871858676,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010720,positive regulation of cell development,344,0.34509208454256,1.53936319982173,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045064,T-helper 2 cell differentiation,14,0.669554228466942,1.68944832739291,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045581,negative regulation of T cell differentiation,24,0.576848579671636,1.68854002232716,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,30,0.619096435241696,1.85678183809834,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046718,viral entry into host cell,99,0.509491744540839,1.95987136884988,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050657,nucleic acid transport,151,-0.392904130200165,-1.61753732439151,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050658,RNA transport,151,-0.392904130200165,-1.61753732439151,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051249,regulation of lymphocyte activation,332,0.333110921319155,1.48000026949898,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060401,cytosolic calcium ion transport,98,0.408810404753007,1.5696078808732,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060644,mammary gland epithelial cell differentiation,12,0.735835226893306,1.79303353325958,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070588,calcium ion transmembrane transport,186,0.350378091054229,1.46540203977494,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0086065,cell communication involved in cardiac conduction,31,0.622250418356614,1.92681162270015,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090279,regulation of calcium ion import,70,0.53263583033609,1.93774621434301,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0098655,cation transmembrane transport,485,0.369334326052219,1.69707006951998,0.00390625,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007015,actin filament organization,261,0.355931704768349,1.55060238414564,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034660,ncRNA metabolic process,452,-0.428739820960217,-1.98493594586237,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045649,regulation of macrophage differentiation,18,0.698708614251473,1.90944729106245,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046632,alpha-beta T cell differentiation,74,0.479344246834074,1.75423974657887,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046685,response to arsenic-containing substance,28,0.603178830855175,1.80649975485062,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051209,release of sequestered calcium ion into cytosol,82,0.455796927565307,1.70890651778446,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051236,establishment of RNA localization,154,-0.392783280988911,-1.62217203351735,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051283,negative regulation of sequestering of calcium ion,82,0.455796927565307,1.70890651778446,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070125,mitochondrial translational elongation,84,-0.55920257486406,-2.12049571335219,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070482,response to oxygen levels,253,0.359606851466489,1.56244091631367,0.00392156862745098,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002694,regulation of leukocyte activation,380,0.321624942183694,1.44334387287518,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009636,response to toxic substance,205,0.374490498648035,1.58617073826157,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010501,RNA secondary structure unwinding,41,-0.52417768986821,-1.73229901792524,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,130,0.398010942592947,1.58412595062998,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0033260,nuclear DNA replication,41,-0.520204164321955,-1.68977669714018,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0033683,nucleotide-excision repair, DNA incision,39,-0.609462971214237,-1.9776517938558,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051216,cartilage development,112,0.391199029057038,1.50840625766709,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051897,positive regulation of protein kinase B signaling,65,0.464325488787704,1.67849709479081,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060713,labyrinthine layer morphogenesis,19,0.679159555919919,1.85514086959881,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070911,global genome nucleotide-excision repair,62,-0.509631165076715,-1.80976510406107,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071902,positive regulation of protein serine/threonine kinase activity,248,0.368050960759332,1.59667872317899,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1903201,regulation of oxidative stress-induced cell death,39,0.507638584446407,1.61241906541342,0.00393700787401575,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002521,leukocyte differentiation,395,0.328569958576651,1.48444245339659,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002696,positive regulation of leukocyte activation,254,0.337445697545999,1.4493705803382,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002761,regulation of myeloid leukocyte differentiation,91,0.461434849269503,1.73250085011046,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006284,base-excision repair,49,-0.540846500105296,-1.81851859105189,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,46,0.491737168776378,1.65680957143547,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010677,negative regulation of cellular carbohydrate metabolic process,31,0.644294994220455,1.97285078357024,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010833,telomere maintenance via telomere lengthening,80,-0.476435178224684,-1.76817898419116,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0015931,nucleobase-containing compound transport,179,-0.371471742657754,-1.57058534903124,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0016049,cell growth,368,0.330564620937757,1.48207205660895,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0019054,modulation by virus of host process,51,-0.598277441211232,-2.03277996922206,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030260,entry into host cell,103,0.50230342581589,1.9369332313791,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030810,positive regulation of nucleotide biosynthetic process,53,0.541690579347881,1.88925955736926,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031346,positive regulation of cell projection organization,231,0.357809046627805,1.55751708758952,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032970,regulation of actin filament-based process,254,0.357297960548931,1.55132998163403,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,57,0.541376593313901,1.88220494786886,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044409,entry into host,103,0.50230342581589,1.9369332313791,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046034,ATP metabolic process,181,0.355434116635995,1.46440537741524,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050767,regulation of neurogenesis,470,0.306519861416277,1.40913713248999,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050867,positive regulation of cell activation,261,0.33459242581295,1.43233541505389,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051251,positive regulation of lymphocyte activation,231,0.348629100160294,1.48111760534403,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051806,entry into cell of other organism involved in symbiotic interaction,103,0.50230342581589,1.9369332313791,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051828,entry into other organism involved in symbiotic interaction,103,0.50230342581589,1.9369332313791,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0052126,movement in host environment,103,0.50230342581589,1.9369332313791,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0052192,movement in environment of other organism involved in symbiotic interaction,103,0.50230342581589,1.9369332313791,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070509,calcium ion import,113,0.464167014205665,1.81119651326294,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1900373,positive regulation of purine nucleotide biosynthetic process,53,0.541690579347881,1.88925955736926,0.00395256916996047,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000722,telomere maintenance via recombination,30,-0.614083871787914,-1.92861516752749,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006271,DNA strand elongation involved in DNA replication,38,-0.568203533121314,-1.84673488235288,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006898,receptor-mediated endocytosis,213,0.349194057016811,1.4836644923292,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006909,phagocytosis,188,0.450583029614309,1.89142425627757,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007052,mitotic spindle organization,75,-0.465561720339855,-1.77038246559879,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009145,purine nucleoside triphosphate biosynthetic process,47,0.486092889037751,1.64269964781012,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032388,positive regulation of intracellular transport,299,0.309241920117382,1.36348944532135,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042093,T-helper cell differentiation,41,0.577635326788664,1.87219825394135,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044003,modification by symbiont of host morphology or physiology,67,-0.529846130973918,-1.88897947959384,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045599,negative regulation of fat cell differentiation,31,0.579681305664791,1.74641751567927,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0050849,negative regulation of calcium-mediated signaling,16,0.702460390302485,1.8929704902287,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051238,sequestering of metal ion,96,0.487163061343671,1.85578937653171,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070124,mitochondrial translational initiation,84,-0.574337619835031,-2.18139273252469,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071216,cellular response to biotic stimulus,163,0.430835582182426,1.75434034239978,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0097553,calcium ion transmembrane import into cytosol,84,0.449844889362557,1.68888272022333,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1902656,calcium ion import into cytosol,84,0.449844889362557,1.68888272022333,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2000514,regulation of CD4-positive, alpha-beta T cell activation,35,0.588117280201524,1.8830370453828,0.00396825396825397,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001525,angiogenesis,316,0.341334393570437,1.5170255229661,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006310,DNA recombination,264,-0.316457765016265,-1.39922652179513,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006414,translational elongation,203,-0.366932173875137,-1.57776598810271,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006956,complement activation,38,0.559777012812029,1.80189111966802,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010959,regulation of metal ion transport,230,0.396199490766808,1.68966656097751,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0016925,protein sumoylation,121,-0.432290692276052,-1.69353314960284,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030198,extracellular matrix organization,247,0.432071686066881,1.84721010526781,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032271,regulation of protein polymerization,151,0.385811097744779,1.56773362028238,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032956,regulation of actin cytoskeleton organization,229,0.341388272029346,1.46243154038818,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0048511,rhythmic process,241,0.415717375959102,1.78970129311581,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0061448,connective tissue development,150,0.389972721500206,1.5717529353895,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070925,organelle assembly,493,-0.310388285325931,-1.45118031624668,0.00398406374501992,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006406,mRNA export from nucleus,76,-0.482087654654275,-1.78171636262099,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030804,positive regulation of cyclic nucleotide biosynthetic process,48,0.496309567205946,1.69586535318331,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031167,rRNA methylation,16,-0.790207148257118,-2.10987716687898,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032200,telomere organization,134,-0.374500085585393,-1.49972099903356,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032680,regulation of tumor necrosis factor production,93,0.43752209276596,1.61770303526019,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042274,ribosomal small subunit biogenesis,46,-0.536485698363518,-1.76537288505735,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044786,cell cycle DNA replication,48,-0.537724650197042,-1.80218246844403,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045912,negative regulation of carbohydrate metabolic process,38,0.610211329482759,1.9284175201687,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071427,mRNA-containing ribonucleoprotein complex export from nucleus,76,-0.482087654654275,-1.78171636262099,0.004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002250,adaptive immune response,299,0.324289447358546,1.42714674902285,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002443,leukocyte mediated immunity,251,0.323124711455387,1.41059267011609,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008033,tRNA processing,140,-0.467757530540751,-1.87797739198467,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0019932,second-messenger-mediated signaling,177,0.388666353627354,1.60383327233151,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030879,mammary gland development,102,0.389013068020432,1.50990198005552,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,184,0.348393993900304,1.43620760632718,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051896,regulation of protein kinase B signaling,97,0.39426735705157,1.53451206319394,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071166,ribonucleoprotein complex localization,91,-0.492138596919566,-1.86508586975909,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071347,cellular response to interleukin-1,68,0.482920313729394,1.75603276049219,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071426,ribonucleoprotein complex export from nucleus,88,-0.491324561033924,-1.85113667198266,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0072577,endothelial cell apoptotic process,34,0.546920039937995,1.71403974822265,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1902105,regulation of leukocyte differentiation,202,0.403414200596487,1.68874158070267,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1902600,hydrogen ion transmembrane transport,89,0.488530793370659,1.83548154924503,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1904062,regulation of cation transmembrane transport,154,0.386456859023473,1.57530680536613,0.00401606425702811,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000154,rRNA modification,20,-0.782439190566116,-2.22114763423915,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001510,RNA methylation,48,-0.584519698227711,-2.02677365553084,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001678,cellular glucose homeostasis,101,0.405800094945652,1.52575276126752,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007189,adenylate cyclase-activating G-protein coupled receptor signaling pathway,34,0.583580385208522,1.78211562516726,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009201,ribonucleoside triphosphate biosynthetic process,52,0.462213918869607,1.60373311485566,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034113,heterotypic cell-cell adhesion,38,0.681703667178665,2.18336148042353,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034250,positive regulation of cellular amide metabolic process,92,0.401298335839892,1.52594119453441,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042036,negative regulation of cytokine biosynthetic process,25,0.597738962941482,1.72969351908939,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043062,extracellular structure organization,248,0.42703068567677,1.82013155134503,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043277,apoptotic cell clearance,26,0.569767838270006,1.68395704839801,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051043,regulation of membrane protein ectodomain proteolysis,17,0.735267460518396,1.95040636302197,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071621,granulocyte chemotaxis,76,0.426235307189719,1.5714328309362,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0097006,regulation of plasma lipoprotein particle levels,44,0.547585107070226,1.83054181215813,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2000377,regulation of reactive oxygen species metabolic process,133,0.430577147410892,1.74809914974203,0.00403225806451613,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0001558,regulation of cell growth,292,0.340637392304097,1.49692864827576,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002287,alpha-beta T cell activation involved in immune response,43,0.571674698474646,1.87488186802442,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002293,alpha-beta T cell differentiation involved in immune response,43,0.571674698474646,1.87488186802442,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002294,CD4-positive, alpha-beta T cell differentiation involved in immune response,43,0.571674698474646,1.87488186802442,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006999,nuclear pore organization,13,-0.726425833217884,-1.76421440954691,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0022616,DNA strand elongation,43,-0.59261533664629,-1.95014866642571,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030316,osteoclast differentiation,72,0.461899034648365,1.62669647002686,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0031344,regulation of cell projection organization,395,0.335840882583988,1.53133517474175,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034470,ncRNA processing,318,-0.471691217676209,-2.10437356652557,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046888,negative regulation of hormone secretion,55,0.491584845982203,1.67527852304311,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0051926,negative regulation of calcium ion transport,32,0.596912570496443,1.88034828672484,0.00404858299595142,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030041,actin filament polymerization,134,0.38211502286084,1.53092179756664,0.0040650406504065,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043370,regulation of CD4-positive, alpha-beta T cell differentiation,31,0.591496702361721,1.82897522284876,0.0040650406504065,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006399,tRNA metabolic process,190,-0.466432354744805,-1.95422253833907,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010976,positive regulation of neuron projection development,170,0.345925618488681,1.43546989570209,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0019048,modulation by virus of host morphology or physiology,61,-0.549423369471517,-1.90989074690362,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0022618,ribonucleoprotein complex assembly,187,-0.351636766214874,-1.48130997251365,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0032543,mitochondrial translation,113,-0.491045600561377,-1.92981949953331,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034114,regulation of heterotypic cell-cell adhesion,15,0.774078756656302,1.96797418516141,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0034381,plasma lipoprotein particle clearance,24,0.704703492537838,2.06745065018559,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042098,T cell proliferation,158,0.371869756676857,1.51440324170203,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0072593,reactive oxygen species metabolic process,200,0.393650327223312,1.67655034548492,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001235,positive regulation of apoptotic signaling pathway,172,0.371555755547506,1.56013196225318,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,54,0.480586445098203,1.68071018651551,0.00408163265306122,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006415,translational termination,177,-0.373914351006577,-1.57152985185891,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,90,0.418280211991739,1.58388911681031,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0042769,DNA damage response, detection of DNA damage,36,-0.616884278958965,-1.92208639148263,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045664,regulation of neuron differentiation,389,0.346385488218765,1.56450137552526,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071826,ribonucleoprotein complex subunit organization,196,-0.356537171569432,-1.51097176384357,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1904872,regulation of telomerase RNA localization to Cajal body,15,-0.725176513754165,-1.90947610147123,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1904874,positive regulation of telomerase RNA localization to Cajal body,15,-0.725176513754165,-1.90947610147123,0.00409836065573771,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006997,nucleus organization,117,-0.418553248525727,-1.64491397228232,0.00411522633744856,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0009451,RNA modification,116,-0.484131581099576,-1.91424598240206,0.00411522633744856,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0010975,regulation of neuron projection development,291,0.340494144275434,1.49450596963333,0.004149377593361,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0020027,hemoglobin metabolic process,15,0.722124157017011,1.86960824213449,0.004149377593361,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0044068,modulation by symbiont of host cellular process,54,-0.571783487963533,-1.95404626740077,0.004149377593361,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1904816,positive regulation of protein localization to chromosome, telomeric region,12,-0.736239914310054,-1.81394486082685,0.004149377593361,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002455,humoral immune response mediated by circulating immunoglobulin,39,0.573549263825756,1.8407634507045,0.00416666666666667,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0030801,positive regulation of cyclic nucleotide metabolic process,56,0.488279967626441,1.70474400547441,0.00416666666666667,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0071243,cellular response to arsenic-containing substance,14,0.827126877935891,2.11088535311724,0.00416666666666667,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0035710,CD4-positive, alpha-beta T cell activation,58,0.587751555196432,2.03334976981324,0.00418410041841004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090670,RNA localization to Cajal body,16,-0.709457610172439,-1.88695124568198,0.00418410041841004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090671,telomerase RNA localization to Cajal body,16,-0.709457610172439,-1.88695124568198,0.00418410041841004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090672,telomerase RNA localization,16,-0.709457610172439,-1.88695124568198,0.00418410041841004,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000460,maturation of 5.8S rRNA,22,-0.654416501105093,-1.89773042242392,0.00420168067226891,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043491,protein kinase B signaling,117,0.420345349691462,1.67980601623428,0.00420168067226891,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0070126,mitochondrial translational termination,86,-0.564311487815231,-2.12277258738494,0.00420168067226891,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0000280,nuclear division,474,-0.316348421580379,-1.45393226541945,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006403,RNA localization,184,-0.408351954588322,-1.70646833194008,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0016072,rRNA metabolic process,154,-0.52125432181954,-2.15776098524027,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043367,CD4-positive, alpha-beta T cell differentiation,52,0.551959082744381,1.87567208784181,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0045981,positive regulation of nucleotide metabolic process,74,0.439814827662166,1.60431308849703,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060259,regulation of feeding behavior,11,0.769476989284698,1.8801035716785,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0061180,mammary gland epithelium development,54,0.503382392050512,1.74347840994893,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:1900544,positive regulation of purine nucleotide metabolic process,74,0.439814827662166,1.60431308849703,0.00421940928270042,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007067,mitotic nuclear division,387,-0.329787725180511,-1.4949510070657,0.00423728813559322,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0046475,glycerophospholipid catabolic process,12,0.720399980315388,1.71643076702892,0.00423728813559322,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0060711,labyrinthine layer development,39,0.554977844662844,1.7497606175725,0.00423728813559322,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002449,lymphocyte mediated immunity,189,0.359741252371849,1.4937488576581,0.00427350427350427,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0002573,myeloid leukocyte differentiation,165,0.37512312288611,1.5174725827541,0.00427350427350427,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,20,0.688236802688601,1.90550045247172,0.00427350427350427,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0043241,protein complex disassembly,290,-0.312018285053842,-1.37109759338801,0.00427350427350427,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0006959,humoral immune response,121,0.443978358025277,1.74878918094652,0.00429184549356223,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0008380,RNA splicing,353,-0.304538819686811,-1.38174076212259,0.00429184549356223,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0019730,antimicrobial humoral response,31,0.553257951051608,1.72415915746896,0.00429184549356223,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0090305,nucleic acid phosphodiester bond hydrolysis,229,-0.424521519049705,-1.80477478924143,0.00429184549356223,0.0451057337952964,0.0345746777729999,BP,mono-sp-vs-hc
GO:0007051,spindle organization,121,-0.408645924862906,-1.64207202179875,0.00431034482758621,0.0451069774281303,0.0345756310488006,BP,mono-sp-vs-hc
GO:0045598,regulation of fat cell differentiation,80,0.454489788787651,1.68420411304713,0.00431034482758621,0.0451069774281303,0.0345756310488006,BP,mono-sp-vs-hc
GO:0006364,rRNA processing,150,-0.528096990864053,-2.16261274028859,0.00432900432900433,0.045109879504784,0.0345778555634405,BP,mono-sp-vs-hc
GO:0035725,sodium ion transmembrane transport,76,0.456751997461683,1.6374955535061,0.00432900432900433,0.045109879504784,0.0345778555634405,BP,mono-sp-vs-hc
GO:0006397,mRNA processing,413,-0.306518358222484,-1.41131802863398,0.0043859649122807,0.0455101813730945,0.034884696998979,BP,mono-sp-vs-hc
GO:0022613,ribonucleoprotein complex biogenesis,361,-0.461421892403247,-2.08905944187995,0.0043859649122807,0.0455101813730945,0.034884696998979,BP,mono-sp-vs-hc
GO:0070202,regulation of establishment of protein localization to chromosome,11,-0.746328394738532,-1.81905932625632,0.00440528634361234,0.0456142307477834,0.0349644534578514,BP,mono-sp-vs-hc
GO:0042254,ribosome biogenesis,224,-0.529078525790702,-2.28444362478984,0.00446428571428571,0.0461278195488722,0.0353581321725366,BP,mono-sp-vs-hc
GO:0046040,IMP metabolic process,12,-0.723678507390885,-1.75870503781719,0.00448430493273543,0.0462373290123224,0.0354420739265732,BP,mono-sp-vs-hc
hsa04540,Gap junction,64,0.471932233644861,1.71612086326884,0.00350877192982456,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04510,Focal adhesion,156,0.428620908354093,1.75444697413228,0.00354609929078014,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04611,Platelet activation,103,0.444895133443961,1.72393446148652,0.00357142857142857,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04924,Renin secretion,42,0.470900460963303,1.58685519204588,0.00359712230215827,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05030,Cocaine addiction,32,0.534400443472015,1.67556917527455,0.0036101083032491,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04918,Thyroid hormone synthesis,59,0.493601219028027,1.72864487034517,0.0036231884057971,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04670,Leukocyte transendothelial migration,93,0.462668712169865,1.74148596352945,0.00364963503649635,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04912,GnRH signaling pathway,73,0.436878541857114,1.59326015577712,0.00364963503649635,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04713,Circadian entrainment,65,0.512924978887196,1.85481941199016,0.00366300366300366,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05322,Systemic lupus erythematosus,108,0.477782173067889,1.86344471111708,0.00366300366300366,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04015,Rap1 signaling pathway,163,0.431820868727003,1.77513221080864,0.003690036900369,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04725,Cholinergic synapse,81,0.462752795687735,1.705616178661,0.003690036900369,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04920,Adipocytokine signaling pathway,63,0.480883166790808,1.74116191260723,0.003690036900369,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04726,Serotonergic synapse,72,0.483814344317011,1.78489846007121,0.0037037037037037,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04730,Long-term depression,48,0.502091093614523,1.73060612406818,0.0037037037037037,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05034,Alcoholism,132,0.538368835863896,2.12464159694332,0.0037037037037037,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05203,Viral carcinogenesis,188,0.408027210300762,1.70779559571908,0.0037037037037037,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04610,Complement and coagulation cascades,58,0.461797830496135,1.60212554358593,0.00371747211895911,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04970,Salivary secretion,58,0.487581891618265,1.70168429625064,0.00371747211895911,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05152,Tuberculosis,153,0.427086844806328,1.74314348024631,0.00371747211895911,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04145,Phagosome,136,0.447840448095877,1.77230867979697,0.00373134328358209,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05202,Transcriptional misregulation in cancer,147,0.425283916690557,1.72031152288515,0.00373134328358209,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04022,cGMP-PKG signaling pathway,125,0.409851917786999,1.63456573952077,0.00374531835205993,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04630,Jak-STAT signaling pathway,116,0.387342684598536,1.54984391597553,0.0037593984962406,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04917,Prolactin signaling pathway,62,0.486171585232272,1.72769627932976,0.0037593984962406,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05416,Viral myocarditis,55,0.605807110202655,2.08879262747297,0.0037593984962406,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04020,Calcium signaling pathway,124,0.387378539016927,1.57162948479479,0.00378787878787879,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04668,TNF signaling pathway,102,0.447855289958498,1.74445884612856,0.00378787878787879,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04723,Retrograde endocannabinoid signaling,62,0.515709497831397,1.84349757676931,0.00378787878787879,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04722,Neurotrophin signaling pathway,105,0.448647454102912,1.74000054476237,0.00381679389312977,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04024,cAMP signaling pathway,140,0.442933497594225,1.77560937343153,0.00383141762452107,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04514,Cell adhesion molecules (CAMs),111,0.453503185454731,1.76024515805693,0.00383141762452107,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04972,Pancreatic secretion,58,0.519092387022961,1.79960512397516,0.00383141762452107,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05145,Toxoplasmosis,109,0.435454871944867,1.6489593135402,0.00383141762452107,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04810,Regulation of actin cytoskeleton,166,0.471155313958803,1.93150073103945,0.00384615384615385,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05133,Pertussis,63,0.493354390929346,1.74192905016141,0.00384615384615385,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04062,Chemokine signaling pathway,156,0.465492331847046,1.91124134686129,0.00386100386100386,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04728,Dopaminergic synapse,94,0.515140944562054,1.9582580367769,0.00386100386100386,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04724,Glutamatergic synapse,79,0.449351611333386,1.66807539812831,0.00387596899224806,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05131,Shigellosis,62,0.584370901239763,2.07403125921061,0.00387596899224806,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04010,MAPK signaling pathway,201,0.414694553655721,1.72896880478191,0.00389105058365759,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05016,Huntington's disease,166,0.433959596125638,1.80091891997799,0.00389105058365759,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05130,Pathogenic Escherichia coli infection,46,0.505527531919243,1.66048133834232,0.00389105058365759,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05160,Hepatitis C,103,0.398192901004095,1.52839510311523,0.00389105058365759,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04014,Ras signaling pathway,166,0.382695415899006,1.58196410229892,0.00390625,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04260,Cardiac muscle contraction,52,0.492605925136583,1.67945897745961,0.00390625,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04720,Long-term potentiation,52,0.568349798672051,1.99577490905201,0.00390625,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04666,Fc gamma R-mediated phagocytosis,84,0.47025473922131,1.77868346370131,0.00392156862745098,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05032,Morphine addiction,57,0.477361538443576,1.69031119929646,0.00396825396825397,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05010,Alzheimer's disease,147,0.412594996889728,1.69433188563464,0.00398406374501992,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04142,Lysosome,119,0.405668231043165,1.58653700634815,0.004,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05012,Parkinson's disease,112,0.44909969681689,1.77386347499457,0.004,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04380,Osteoclast differentiation,126,0.444318862018209,1.75175985998155,0.00401606425702811,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa03430,Mismatch repair,23,-0.629529915045521,-1.77203921050085,0.00403225806451613,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa03450,Non-homologous end-joining,12,-0.698162467982164,-1.69075992579222,0.00403225806451613,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04660,T cell receptor signaling pathway,95,0.39118050232453,1.49146841757059,0.00403225806451613,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa00190,Oxidative phosphorylation,110,0.441482267194533,1.7616794557721,0.00404858299595142,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa03030,DNA replication,36,-0.536936465864109,-1.72362150416498,0.00404858299595142,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04390,Hippo signaling pathway,124,0.378893908954594,1.51095016733121,0.00408163265306122,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05140,Leishmaniasis,69,0.475917992081257,1.67520354479102,0.00408163265306122,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05169,Epstein-Barr virus infection,194,0.386115043120853,1.61347352542154,0.00408163265306122,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa05100,Bacterial invasion of epithelial cells,70,0.479792738371929,1.73643753142892,0.00409836065573771,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa03410,Base excision repair,33,-0.514700597165304,-1.61584067590248,0.00413223140495868,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa03420,Nucleotide excision repair,45,-0.526135144722854,-1.77289041537963,0.00416666666666667,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa03008,Ribosome biogenesis in eukaryotes,70,-0.605716649284881,-2.28405003041699,0.00423728813559322,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04932,Non-alcoholic fatty liver disease (NAFLD),138,0.396621812124448,1.61537794473892,0.00429184549356223,0.018337885290675,0.0106782758691501,KG,mono-sp-vs-hc
hsa04141,Protein processing in endoplasmic reticulum,158,0.335958573111048,1.39947056536282,0.00704225352112676,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa04911,Insulin secretion,55,0.482498642265916,1.65253797838572,0.00706713780918728,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05414,Dilated cardiomyopathy,64,0.432437679812751,1.55454797159473,0.00709219858156028,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05205,Proteoglycans in cancer,165,0.36226020091925,1.48523237677127,0.00719424460431655,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05215,Prostate cancer,79,0.423055348567186,1.5510989646382,0.0075187969924812,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa04210,Apoptosis,131,0.38766356392212,1.52543066023061,0.00757575757575758,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05164,Influenza A,149,0.360175642278562,1.45951967733555,0.00760456273764259,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),56,0.504453330259588,1.74247315253918,0.00766283524904215,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05144,Malaria,37,0.503494353818181,1.61359304006668,0.00772200772200772,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa04910,Insulin signaling pathway,119,0.351655167400454,1.42383270907554,0.00775193798449612,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa05168,Herpes simplex infection,166,0.347005491903842,1.41682201724111,0.00778210116731518,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa00280,Valine, leucine and isoleucine degradation,43,-0.497595739850004,-1.66879750683949,0.0078740157480315,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa00480,Glutathione metabolism,44,0.500375788181637,1.69407793661632,0.0078740157480315,0.0281072460879099,0.0163670413949755,KG,mono-sp-vs-hc
hsa03013,RNA transport,151,-0.412496783890112,-1.67696678485421,0.0087719298245614,0.0309210526315789,0.018005540166205,KG,mono-sp-vs-hc
hsa05206,MicroRNAs in cancer,132,0.395973316103442,1.60271673831386,0.010989010989011,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa05200,Pathways in cancer,318,0.289528819819132,1.27665474421642,0.0111524163568773,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa04971,Gastric acid secretion,57,0.425548864778762,1.49510095003221,0.0112359550561798,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa04146,Peroxisome,75,-0.419691650259149,-1.56003142336909,0.0114503816793893,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa04915,Estrogen signaling pathway,84,0.40519449746213,1.49576770427041,0.0114503816793893,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa05212,Pancreatic cancer,65,0.40987679742232,1.45273513260287,0.0114503816793893,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa04612,Antigen processing and presentation,65,0.403603202357482,1.45296963624932,0.0114942528735632,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa04933,AGE-RAGE signaling pathway in diabetic complications,85,0.392293866958866,1.45490157417004,0.0115384615384615,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa04068,FoxO signaling pathway,123,0.362047974740093,1.41525613964724,0.0115830115830116,0.0367012277124637,0.0213713755996429,KG,mono-sp-vs-hc
hsa05132,Salmonella infection,74,0.412661150150003,1.48649917773102,0.0118110236220472,0.0367458628328194,0.0213973669351244,KG,mono-sp-vs-hc
hsa04922,Glucagon signaling pathway,81,0.403661173456664,1.51030509845328,0.0118577075098814,0.0367458628328194,0.0213973669351244,KG,mono-sp-vs-hc
hsa04520,Adherens junction,65,0.437021043507657,1.56501416356485,0.0148148148148148,0.0451127819548872,0.0262694810935513,KG,mono-sp-vs-hc
hsa04261,Adrenergic signaling in cardiomyocytes,112,0.384059146531919,1.49656604013408,0.0149253731343284,0.0451127819548872,0.0262694810935513,KG,mono-sp-vs-hc
hsa05031,Amphetamine addiction,45,0.494196186472928,1.66290475473607,0.0150375939849624,0.0451127819548872,0.0262694810935513,KG,mono-sp-vs-hc
hsa05166,HTLV-I infection,231,0.31070193562759,1.33163234061368,0.0155038759689922,0.0460220318237454,0.0267989435031888,KG,mono-sp-vs-hc
hsa04750,Inflammatory mediator regulation of TRP channels,76,0.402883457827755,1.47873229485743,0.0156862745098039,0.046078431372549,0.0268317853457172,KG,mono-sp-vs-hc
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,60,0.409728080858867,1.45569873161882,0.0158730158730159,0.046146293568974,0.0268713019662558,KG,mono-sp-vs-hc
hsa04662,B cell receptor signaling pathway,69,0.444070323874202,1.61046702200812,0.0167364016736402,0.0481598497139442,0.0280438094638869,KG,mono-sp-vs-hc
hsa04064,NF-kappa B signaling pathway,83,0.413924738350867,1.53956041975153,0.0170212765957447,0.0484848484848485,0.0282330584682208,KG,mono-sp-vs-hc
hsa04925,Aldosterone synthesis and secretion,59,0.424622610915003,1.49134789520323,0.0179856115107914,0.0507194244604317,0.0295342673229837,KG,mono-sp-vs-hc
hsa04744,Phototransduction,17,0.573162239024822,1.54366708175357,0.018450184501845,0.051009333622748,0.0297030834085431,KG,mono-sp-vs-hc
hsa04964,Proximal tubule bicarbonate reclamation,16,0.61568033640014,1.64173403638621,0.018450184501845,0.051009333622748,0.0297030834085431,KG,mono-sp-vs-hc
hsa05221,Acute myeloid leukemia,56,0.427298542316892,1.4776437845256,0.0193050193050193,0.0528545188739364,0.030777547384599,KG,mono-sp-vs-hc
hsa05110,Vibrio cholerae infection,44,0.474216893285409,1.56794851929982,0.01953125,0.0529597355769231,0.0308388157894737,KG,mono-sp-vs-hc
hsa05146,Amoebiasis,75,0.402956347767094,1.45854491738319,0.0204081632653061,0.0548104956268222,0.0319165260088998,KG,mono-sp-vs-hc
hsa00062,Fatty acid elongation,19,-0.557413527333599,-1.50510747955903,0.0214592274678112,0.0566777208320772,0.0330038240007616,KG,mono-sp-vs-hc
hsa04270,Vascular smooth muscle contraction,83,0.372963903698711,1.38019052447964,0.021505376344086,0.0566777208320772,0.0330038240007616,KG,mono-sp-vs-hc
hsa04151,PI3K-Akt signaling pathway,245,0.32338374242262,1.37014375109643,0.0237154150197628,0.0619235836627141,0.0360585257610429,KG,mono-sp-vs-hc
hsa05150,Staphylococcus aureus infection,48,0.419864550417088,1.42854189096179,0.0261194029850746,0.0672114402451481,0.0391376807698511,KG,mono-sp-vs-hc
hsa05410,Hypertrophic cardiomyopathy (HCM),61,0.41549244096472,1.45014727436262,0.0262172284644195,0.0672114402451481,0.0391376807698511,KG,mono-sp-vs-hc
hsa04530,Tight junction,102,0.355642526757563,1.36990726914429,0.0268199233716475,0.0677884615384615,0.0394736842105263,KG,mono-sp-vs-hc
hsa04978,Mineral absorption,40,0.476639774448153,1.52392728071776,0.0269230769230769,0.0677884615384615,0.0394736842105263,KG,mono-sp-vs-hc
hsa04060,Cytokine-cytokine receptor interaction,186,0.312058024516318,1.30352348045238,0.0335820895522388,0.0838066305639942,0.0488011734527178,KG,mono-sp-vs-hc
DOID:170,endocrine gland cancer,392,0.318566432480988,1.42718611741952,0.00348432055749129,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0060085,organ system benign neoplasm,186,0.389539136204371,1.61336980249799,0.00352112676056338,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:10283,prostate cancer,332,0.336986999269301,1.50898533243006,0.003584229390681,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3856,male reproductive organ cancer,340,0.33521245404174,1.50479450388385,0.003584229390681,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3393,coronary artery disease,245,0.351618674941392,1.50332459154459,0.00359712230215827,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:9351,diabetes mellitus,476,0.329636782589022,1.50186477240975,0.00359712230215827,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:104,bacterial infectious disease,221,0.363344752984839,1.54531356164882,0.0036101083032491,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:74,hematopoietic system disease,377,0.323048113989444,1.45325564036864,0.0036101083032491,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3908,non-small cell lung carcinoma,334,0.340321846600404,1.52576790581989,0.0036231884057971,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1037,lymphoblastic leukemia,347,0.333822761196508,1.48829120918492,0.00363636363636364,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2377,multiple sclerosis,134,0.37135281073946,1.47689438095654,0.00363636363636364,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:10652,Alzheimer's disease,335,0.389641063426011,1.74042935505767,0.00364963503649635,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1800,neuroendocrine carcinoma,14,0.82938327414744,2.12941611629889,0.00364963503649635,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3213,demyelinating disease,137,0.383906152281367,1.52669535025489,0.00364963503649635,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3905,lung carcinoma,398,0.332087769475832,1.51202074338684,0.00364963503649635,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:680,tauopathy,338,0.384058754399631,1.7112315031896,0.00364963503649635,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1612,breast cancer,419,0.339586932990569,1.53454675789001,0.00366300366300366,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:201,connective tissue cancer,300,0.379133980675156,1.66026339740278,0.00366300366300366,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:5093,thoracic cancer,419,0.339586932990569,1.53454675789001,0.00366300366300366,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1247,blood coagulation disease,143,0.4314740101969,1.73068953348861,0.00367647058823529,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:326,ischemia,163,0.421825030360826,1.74449659858335,0.003690036900369,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3459,breast carcinoma,312,0.350371233801042,1.54341958668093,0.003690036900369,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:6000,congestive heart failure,149,0.440141088465226,1.76600855053798,0.003690036900369,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:9970,obesity,222,0.396227655843181,1.68134008616754,0.003690036900369,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0060180,colitis,46,0.589052887968303,2.01621409518262,0.0037037037037037,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:184,bone cancer,196,0.350558978972565,1.45548745301739,0.0037037037037037,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:5419,schizophrenia,468,0.353377568122791,1.59920012590235,0.0037037037037037,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:8577,ulcerative colitis,46,0.589052887968303,2.01621409518262,0.0037037037037037,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:865,vasculitis,99,0.429630624571415,1.62021639891992,0.0037037037037037,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:120,female reproductive organ cancer,358,0.331030190085812,1.47455161548809,0.00371747211895911,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:654,overnutrition,228,0.396756052026489,1.68924957324267,0.00371747211895911,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:9352,type 2 diabetes mellitus,154,0.417520495132969,1.68821169043586,0.00371747211895911,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0050589,inflammatory bowel disease,61,0.57124240006546,2.03749805517114,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0050615,respiratory system cancer,471,0.325095615347768,1.49442744714161,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:10763,hypertension,405,0.368711012647228,1.64827123511212,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1324,lung cancer,463,0.325151768867248,1.49120950860319,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2468,psychotic disorder,471,0.353481131737764,1.59957586680196,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:374,nutrition disease,238,0.380901766026658,1.63083238039316,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:557,kidney disease,335,0.360424846444733,1.61049980074911,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:6713,cerebrovascular disease,81,0.539120729314464,1.98404355786699,0.00373134328358209,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1074,kidney failure,111,0.499328362781794,1.93592921249993,0.00374531835205993,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:18,urinary system disease,345,0.356250875281664,1.59466843203282,0.00374531835205993,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2214,inherited blood coagulation disease,14,0.73720973001397,1.88547822824145,0.00374531835205993,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:5844,myocardial infarction,197,0.367133011642127,1.5264388056067,0.00374531835205993,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:10159,osteonecrosis,22,0.590174569914997,1.69077512432144,0.0037593984962406,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:13241,Behcet's disease,69,0.47107476546577,1.68572488365931,0.0037593984962406,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:526,Human immunodeficiency virus infectious disease,144,0.381971640685861,1.52940586368082,0.0037593984962406,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:936,brain disease,314,0.371158336519056,1.62694165585473,0.0037593984962406,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0050338,primary bacterial infectious disease,193,0.353201727790013,1.48100014590272,0.00377358490566038,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:12365,malaria,86,0.433470236516137,1.61289057124199,0.00377358490566038,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2237,hepatitis,358,0.322072192435677,1.4350478729077,0.00377358490566038,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3407,carotid artery disease,12,0.76764900869591,1.81835781983682,0.00377358490566038,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0060084,cell type benign neoplasm,342,0.3049452851309,1.36575674684617,0.00378787878787879,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0060100,musculoskeletal system cancer,354,0.370617803075821,1.64679899929198,0.00378787878787879,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:114,heart disease,357,0.338613162629664,1.50181643811038,0.00378787878787879,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3996,urinary system cancer,378,0.320428011245494,1.43302264385168,0.00380228136882129,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0080008,ischemic bone disease,30,0.552650068201171,1.7013584640142,0.00381679389312977,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1168,familial hyperlipidemia,59,0.482112615659535,1.69054138497952,0.00381679389312977,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:263,kidney cancer,330,0.309864819950142,1.37655842878975,0.00383141762452107,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3454,brain infarction,43,0.555526076089727,1.82121025197983,0.00383141762452107,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:783,end stage renal failure,27,0.589287988939905,1.74750200078445,0.00383141762452107,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2394,ovarian cancer,253,0.33415223333978,1.44336545474136,0.00384615384615385,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3312,bipolar disorder,110,0.410923988473238,1.59579377781736,0.00387596899224806,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:784,chronic kidney failure,49,0.526004837771395,1.76906849270948,0.00387596899224806,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:8778,Crohn's disease,34,0.554044604322559,1.70974998266361,0.00387596899224806,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0060072,benign neoplasm,409,0.32025223614859,1.44560845114714,0.00389105058365759,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0080005,bone remodeling disease,98,0.436194570925301,1.65063020967987,0.00389105058365759,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1936,atherosclerosis,263,0.396332293935017,1.69941007777509,0.00389105058365759,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3324,mood disorder,134,0.393955184057627,1.56471563122154,0.00389105058365759,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:4451,renal carcinoma,291,0.308233979234243,1.34849333208238,0.00389105058365759,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:7693,abdominal aortic aneurysm,36,0.632509727414543,2.01780048199568,0.00389105058365759,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2348,arteriosclerotic cardiovascular disease,264,0.391709407421854,1.67991765076135,0.00390625,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2349,arteriosclerosis,272,0.390144044487353,1.67504234723851,0.00390625,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2513,basal cell carcinoma,20,0.626697848509446,1.76390025208633,0.00390625,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:417,hypersensitivity reaction type II disease,458,0.34334322900831,1.58029063591532,0.00390625,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:8398,osteoarthritis,138,0.383843761340262,1.54100738106033,0.00390625,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:13810,familial hypercholesterolemia,14,0.740602118770567,1.88127609470582,0.00392156862745098,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2621,autonomic nervous system neoplasm,275,0.387500816491061,1.69802647323825,0.00395256916996047,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:5295,intestinal disease,98,0.506274845662256,1.90934573361277,0.00395256916996047,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:769,neuroblastoma,275,0.387500816491061,1.69802647323825,0.00395256916996047,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0070004,myeloma,262,0.379733143342203,1.64889883920142,0.00396825396825397,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3146,lipid metabolism disorder,67,0.475668345634396,1.69915936553372,0.00396825396825397,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:850,lung disease,361,0.321945727562713,1.44773698688992,0.00396825396825397,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1192,peripheral nervous system neoplasm,289,0.377830016368379,1.65694399172131,0.00398406374501992,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3498,pancreatic ductal adenocarcinoma,81,0.469084112221796,1.71612139627863,0.00398406374501992,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3627,aortic aneurysm,46,0.660858958948196,2.22859461206097,0.00398406374501992,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:520,aortic disease,46,0.660858958948196,2.22859461206097,0.00398406374501992,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3083,chronic obstructive pulmonary disease,166,0.374010112888653,1.54224296968581,0.004,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:2320,obstructive lung disease,223,0.356880737928026,1.52878871274943,0.00401606425702811,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0050161,lower respiratory tract disease,369,0.332197102057243,1.49383733600261,0.00403225806451613,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3211,lysosomal storage disease,115,0.434751194010735,1.70694111677158,0.00403225806451613,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:4960,bone marrow cancer,267,0.375947050619854,1.63158223361069,0.00403225806451613,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:1579,respiratory system disease,410,0.321448219933486,1.46425220861109,0.00404858299595142,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:7148,rheumatoid arthritis,433,0.360880453262382,1.6204907411407,0.00404858299595142,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:3093,nervous system cancer,419,0.360959663562778,1.63920459907898,0.0040650406504065,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:9455,lipid storage disease,95,0.437305027922847,1.65668317283652,0.0040650406504065,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:9538,multiple myeloma,217,0.377904328833168,1.60623891487216,0.0040650406504065,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:811,lipodystrophy,28,0.657604036209149,1.93054428336235,0.00409836065573771,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:9452,fatty liver disease,68,0.479976907868057,1.72189972750324,0.00409836065573771,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:11714,gestational diabetes,43,0.530161541533229,1.71711682696695,0.00413223140495868,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:0060122,integumentary system cancer,76,0.45148279505272,1.65169018362415,0.004149377593361,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:4159,skin cancer,76,0.45148279505272,1.65169018362415,0.004149377593361,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:715,T-cell leukemia,53,0.479038711742448,1.652064978868,0.00416666666666667,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:583,hemolytic anemia,46,0.528142335348783,1.727438453191,0.00418410041841004,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:720,normocytic anemia,46,0.528142335348783,1.727438453191,0.00418410041841004,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:4676,uremia,14,0.728819207101262,1.81703727624186,0.00420168067226891,0.0286189947677184,0.0198192484540986,DO,mono-sp-vs-hc
DOID:10608,celiac disease,71,0.443370180836642,1.60284907143744,0.00432900432900433,0.0292106647246834,0.020228992191609,DO,mono-sp-vs-hc
DOID:3451,skin carcinoma,46,0.594081776523481,1.9440073243639,0.00442477876106195,0.0295804654211734,0.0204850868567683,DO,mono-sp-vs-hc
DOID:9408,acute myocardial infarction,68,0.464709400681722,1.64410649475852,0.00694444444444444,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:2218,blood platelet disease,80,0.458426747509701,1.69746957077418,0.00709219858156028,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1398,parasitic infectious disease,120,0.391900997836893,1.55261241263488,0.00716845878136201,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:2213,hemorrhagic disease,126,0.393764833226849,1.54780362157482,0.0072992700729927,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1588,thrombocytopenia,57,0.459830520043569,1.63246168881956,0.00732600732600733,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:10534,stomach cancer,203,0.362746324088094,1.53645934194804,0.00738007380073801,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:8552,chronic myeloid leukemia,23,0.605804705728099,1.68207688105763,0.00738007380073801,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1826,epilepsy syndrome,141,0.405377716168475,1.63106556574865,0.00740740740740741,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:2151,malignant ovarian surface epithelial-stromal neoplasm,232,0.331485576470312,1.41551034823099,0.00740740740740741,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:2152,ovary epithelial cancer,232,0.331485576470312,1.41551034823099,0.00740740740740741,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:4001,ovarian carcinoma,232,0.331485576470312,1.41551034823099,0.00740740740740741,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1116,pertussis,30,0.565084298479484,1.72864560032622,0.00743494423791822,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:409,liver disease,495,0.290808342308561,1.33332905385031,0.00743494423791822,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1307,dementia,112,0.426651613154548,1.67540716101669,0.00749063670411985,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:0050339,commensal bacterial infectious disease,34,0.548008187016351,1.7038403006527,0.0075187969924812,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1793,pancreatic cancer,245,0.341531768079879,1.47578232634313,0.0075187969924812,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:13580,cholestasis,47,0.51477869339324,1.6779277387682,0.00754716981132075,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:28,endocrine system disease,278,0.323052062126747,1.39979221997501,0.00757575757575758,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:1602,lymphadenitis,46,0.526734979496765,1.73406713471699,0.00772200772200772,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:9942,lymph node disease,46,0.526734979496765,1.73406713471699,0.00772200772200772,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:10603,glucose intolerance,37,0.530093432063074,1.67609420573214,0.00775193798449612,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:62,aortic valve disease,19,0.629344224238481,1.6827388837272,0.00775193798449612,0.0430530709600477,0.0298151460942159,DO,mono-sp-vs-hc
DOID:4195,hyperglycemia,106,0.422322260531704,1.61694098673828,0.00796812749003984,0.0434285714285714,0.0300751879699248,DO,mono-sp-vs-hc
DOID:1107,esophageal carcinoma,94,0.39469927190604,1.5000820791255,0.008,0.0434285714285714,0.0300751879699248,DO,mono-sp-vs-hc
DOID:2018,hyperinsulinism,37,0.533929619587428,1.69005202573222,0.008,0.0434285714285714,0.0300751879699248,DO,mono-sp-vs-hc
DOID:1428,endocrine pancreas disease,42,0.502874614953178,1.62915621454838,0.00809716599190283,0.0436280137772675,0.030213305939936,DO,mono-sp-vs-hc
DOID:37,skin disease,250,0.3221560128304,1.38704916107689,0.00819672131147541,0.0438372799028537,0.0303582270795386,DO,mono-sp-vs-hc
DOID:0060031,autoimmune disease of gastrointestinal tract,86,0.42215201978913,1.59090666785208,0.00836820083682008,0.0444253015013537,0.030765444253015,DO,mono-sp-vs-hc
DOID:11612,polycystic ovary syndrome,125,0.37589161753865,1.47345941257871,0.00986842105263158,0.052007299270073,0.0360161352285824,DO,mono-sp-vs-hc
DOID:26,pancreas disease,119,0.409004993084164,1.59306787555919,0.0108303249097473,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:6364,migraine,45,0.483597773673458,1.60330657455893,0.0109489051094891,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:10825,essential hypertension,79,0.434470845294292,1.57177350113959,0.011070110701107,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:381,arthropathy,70,0.414126778007724,1.50983969710037,0.0111111111111111,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:1921,Klinefelter's syndrome,13,0.655794645738697,1.6705856715287,0.0112781954887218,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:341,peripheral vascular disease,49,0.488942992785827,1.63796265115278,0.0112781954887218,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:4989,pancreatitis,84,0.446413050927741,1.64247293373186,0.0112781954887218,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:200,giant cell tumor,15,0.673895680768085,1.74099205956655,0.0113207547169811,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:10591,pre-eclampsia,194,0.381956821663553,1.58537140526164,0.0113636363636364,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:2916,hypersensitivity reaction type IV disease,68,0.436170940947348,1.54973285804726,0.0113636363636364,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:3829,pituitary adenoma,44,0.511867502239051,1.69691319339407,0.0113636363636364,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:399,tuberculosis,123,0.36154918484139,1.42419484251759,0.0114068441064639,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:3371,chondrosarcoma,52,0.464886403855078,1.57784162029029,0.0114942528735632,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:1712,aortic valve stenosis,15,0.653273818074823,1.65469680531477,0.0115384615384615,0.0551706571574121,0.0382068262862965,DO,mono-sp-vs-hc
DOID:0080011,bone resorption disease,65,0.418789885138815,1.47637577883292,0.0117647058823529,0.055317192767392,0.0383083052405762,DO,mono-sp-vs-hc
DOID:1115,sarcoma,153,0.368528304010753,1.48988412151715,0.0118577075098814,0.055317192767392,0.0383083052405762,DO,mono-sp-vs-hc
DOID:4905,pancreatic carcinoma,184,0.340141582744815,1.41879436110543,0.0118577075098814,0.055317192767392,0.0383083052405762,DO,mono-sp-vs-hc
DOID:1532,pleural disease,18,0.606908534650676,1.66233960032277,0.0119521912350598,0.055317192767392,0.0383083052405762,DO,mono-sp-vs-hc
DOID:576,proteinuria,50,0.45955951558546,1.56569039104921,0.0119521912350598,0.055317192767392,0.0383083052405762,DO,mono-sp-vs-hc
DOID:767,muscular atrophy,41,0.465757530986983,1.50663828325598,0.0120967741935484,0.0556297513868913,0.0385247585781796,DO,mono-sp-vs-hc
DOID:16,integumentary system disease,286,0.305720853749907,1.33337142484278,0.0123456790123457,0.0564150648538834,0.0390686044694484,DO,mono-sp-vs-hc
DOID:10747,lymphoid leukemia,60,0.462515697001398,1.63009554824503,0.0125,0.0567610062893082,0.0393081761006289,DO,mono-sp-vs-hc
DOID:12206,dengue hemorrhagic fever,13,0.709231325808747,1.70860151970202,0.0128205128205128,0.0578525641025641,0.0400641025641026,DO,mono-sp-vs-hc
DOID:3151,skin squamous cell carcinoma,18,0.656516159022878,1.75022719536887,0.0131004366812227,0.0587485421356695,0.0406845859665301,DO,mono-sp-vs-hc
DOID:2789,parasitic protozoa infectious disease,102,0.40177994512972,1.54490044738169,0.0144927536231884,0.0644355198572066,0.0446229361892013,DO,mono-sp-vs-hc
DOID:13378,Kawasaki disease,42,0.507826757130689,1.65383346858693,0.0145985401459854,0.0644355198572066,0.0446229361892013,DO,mono-sp-vs-hc
DOID:2228,thrombocytosis,29,0.537264143920987,1.6246581626278,0.014760147601476,0.0644355198572066,0.0446229361892013,DO,mono-sp-vs-hc
DOID:3347,osteosarcoma,177,0.334790600159826,1.37941349190694,0.014760147601476,0.0644355198572066,0.0446229361892013,DO,mono-sp-vs-hc
DOID:1927,sphingolipidosis,27,0.534588697186785,1.61419979092931,0.0148148148148148,0.0644355198572066,0.0446229361892013,DO,mono-sp-vs-hc
DOID:1883,hepatitis C,198,0.342111805314886,1.43448619166601,0.0150375939849624,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:12554,hemolytic-uremic syndrome,17,0.649214142338966,1.71657670749298,0.0152091254752852,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:657,adenoma,236,0.323654461663701,1.38447410632111,0.0152091254752852,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:0060089,endocrine organ benign neoplasm,69,0.431426328351662,1.50957878160843,0.0154440154440154,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:2921,glomerulonephritis,57,0.455256734045342,1.57937279243825,0.0155038759689922,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:1070,primary open angle glaucoma,39,0.51800621633682,1.6145579371482,0.0155642023346304,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:11335,sarcoidosis,64,0.44148979431817,1.54185514195717,0.015625,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:4254,osteosclerosis,15,0.658732785933245,1.71627727530884,0.015625,0.0648347701149425,0.0448994252873563,DO,mono-sp-vs-hc
DOID:655,inherited metabolic disorder,249,0.324511875968365,1.38136645212656,0.0159362549800797,0.0657484348321002,0.045532157085942,DO,mono-sp-vs-hc
DOID:1459,hypothyroidism,31,0.51617780097124,1.59954685251925,0.0163934426229508,0.0672503725782414,0.0465722801788376,DO,mono-sp-vs-hc
DOID:2355,anemia,197,0.330746867248907,1.37542293016882,0.016597510373444,0.0677028389244438,0.0468856225238531,DO,mono-sp-vs-hc
DOID:403,mouth disease,131,0.355536875156508,1.42211779954353,0.0169491525423729,0.0687488097505237,0.0476099790516092,DO,mono-sp-vs-hc
